Articles for tag: COVAXPandemic TreatyPrivate OrderingWHO

Power and Distribution in Global Health Governance

Since at least the 1980s, private actors and market-based mechanisms have played an increasingly important role in the provision of public goods and services and the pursuit of public policy objectives in general. A market approach is also widely used in the field of public health. In effect, the PPP approach, as illustrated by COVAX, can work to structurally protect the interests of (a majority) of the high-income countries. While PPPs in global health may do a lot of good things, their private law, contractualist nature and structures safeguard formal state sovereignty and voluntarism, predominantly benefitting high-income donor countries

The EU’s and UK’s Self-Defeating Vaccine Nationalism

The European Union and the United Kingdom currently risk being victims of their own vaccine nationalism. The time-pressure for securing as many vaccine doses against COVID-19 as possible has led to hiccups and even tensions between both. At the heart of the matter is AstraZeneca’s delay in distributing a given number of doses in the European Union. Meanwhile, it continues to serve the United Kingdom in a timely fashion. The threat of imposing export restrictions is now on the table.